Clinical Trial Update: Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intracoronary autologous mesenchymal stem cell implantation for ischemic dilated cardiomyopathy, sponsored by National University of Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Dilated Cardiomyopathy

Drugs mentioned

• Autologous mesenchymal stem cells for intracoronary implantation (mesenchymal stem cells)

Snippet

Sponsor: National University of Malaysia | Conditions: Ischemic Dilated Cardiomyopathy | Phase 2 | Status: UNKNOWN